-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

UBS Maintains Neutral on Oak Street Health, Lowers Price Target to $21

Benzinga · 01/06/2023 08:44
UBS analyst Andrew Mok maintains Oak Street Health (NYSE:OSH) with a Neutral and lowers the price target from $28 to $21.